[Association between hypertension duration and chronic kidney disease in residents in China].

Q1 Medicine
X Zhang, M Zhang, C Li, M T Yu, L M Wang
{"title":"[Association between hypertension duration and chronic kidney disease in residents in China].","authors":"X Zhang, M Zhang, C Li, M T Yu, L M Wang","doi":"10.3760/cma.j.cn112338-20240411-00187","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> To evaluate the association between hypertension duration and risk for chronic kidney disease in residents in China. <b>Methods:</b> Participants aged 18-74 years from the sixth round of China Chronic Disease and Risk Factor Surveillance in 2018 were included. The age/date at hypertension diagnosis was reported by them, and hypertension duration was calculated based on the age at diagnosis and the age at survey. The hypertension duration was calculated as 0 year (i.e., normotensive participants), 0.1- year, 5.0- years, 10.0- years, and ≥15.0 years. Serum creatinine, urinary albumin, and urinary creatinine levels were measured, and chronic kidney disease was diagnosed when glomerular filtration rate was <60 ml·min<sup>-1</sup>·(1.73 m<sup>2</sup>)<sup>-1</sup> and/or urine albumin-to-creatinine ratio was ≥30 mg/g. Multivariable logistic regression analysis, which took intra-group correlation into account, was used to evaluate the association of hypertension duration with chronic kidney disease. <b>Results:</b> A total of 140 662 residents were finally included in the analysis. After adjusting the confounders, including blood pressure, the odds ratio of chronic kidney disease was 1.16 (95%<i>CI</i>: 1.09-1.23), 1.33 (95%<i>CI</i>: 1.20-1.48), 1.33 (95%<i>CI</i>: 1.18-1.49), and 1.43 (95%<i>CI</i>: 1.29-1.60) in study subjects with hypertension durations of 0.1-4.9 years, 5.0-9.9 years, 10.0-14.9 years, and ≥15.0 years, respectively, in comparison with normotensive people. This result was further supported by the positive association between hypertension duration and chronic kidney disease in people with previously diagnosed hypertension. The results of restricted cubic spline suggested that the risk for chronic kidney disease showed a steep increase within 0.1- 4.9 years after hypertension diagnosis, then showed neither increase nor decrease. The above association seemed to be stronger in those with hypertension diagnosed age <45 years. Compared with those with hypertension duration of 0.1-4.9 years, the odds ratio was 1.38 (95%<i>CI</i>: 1.04-1.84), 1.22 (95%<i>CI</i>: 0.91-1.65), and 1.47 (95%<i>CI</i>: 1.04-2.07) in those with hypertension durations of 5.0-9.9 years, 10.0-14.9 years, and ≥15.0 year, respectively. In those with hypertension diagnosis at ≥45 years, the corresponding odds ratio was 1.08 (95%<i>CI</i>: 0.98-1.19), 1.08 (95%<i>CI</i>: 0.97-1.21), and 1.16 (95%<i>CI</i>: 1.02-1.32), respectively. <b>Conclusions:</b> Hypertension duration is positively associated with the risk for chronic kidney disease in residents in China, and this association is independent of blood pressure level. Early diagnosis of hypertension and long-term control of blood pressure are effective strategies for secondary prevention of hypertension-related chronic kidney disease.</p>","PeriodicalId":23968,"journal":{"name":"中华流行病学杂志","volume":"46 1","pages":"26-32"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华流行病学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112338-20240411-00187","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To evaluate the association between hypertension duration and risk for chronic kidney disease in residents in China. Methods: Participants aged 18-74 years from the sixth round of China Chronic Disease and Risk Factor Surveillance in 2018 were included. The age/date at hypertension diagnosis was reported by them, and hypertension duration was calculated based on the age at diagnosis and the age at survey. The hypertension duration was calculated as 0 year (i.e., normotensive participants), 0.1- year, 5.0- years, 10.0- years, and ≥15.0 years. Serum creatinine, urinary albumin, and urinary creatinine levels were measured, and chronic kidney disease was diagnosed when glomerular filtration rate was <60 ml·min-1·(1.73 m2)-1 and/or urine albumin-to-creatinine ratio was ≥30 mg/g. Multivariable logistic regression analysis, which took intra-group correlation into account, was used to evaluate the association of hypertension duration with chronic kidney disease. Results: A total of 140 662 residents were finally included in the analysis. After adjusting the confounders, including blood pressure, the odds ratio of chronic kidney disease was 1.16 (95%CI: 1.09-1.23), 1.33 (95%CI: 1.20-1.48), 1.33 (95%CI: 1.18-1.49), and 1.43 (95%CI: 1.29-1.60) in study subjects with hypertension durations of 0.1-4.9 years, 5.0-9.9 years, 10.0-14.9 years, and ≥15.0 years, respectively, in comparison with normotensive people. This result was further supported by the positive association between hypertension duration and chronic kidney disease in people with previously diagnosed hypertension. The results of restricted cubic spline suggested that the risk for chronic kidney disease showed a steep increase within 0.1- 4.9 years after hypertension diagnosis, then showed neither increase nor decrease. The above association seemed to be stronger in those with hypertension diagnosed age <45 years. Compared with those with hypertension duration of 0.1-4.9 years, the odds ratio was 1.38 (95%CI: 1.04-1.84), 1.22 (95%CI: 0.91-1.65), and 1.47 (95%CI: 1.04-2.07) in those with hypertension durations of 5.0-9.9 years, 10.0-14.9 years, and ≥15.0 year, respectively. In those with hypertension diagnosis at ≥45 years, the corresponding odds ratio was 1.08 (95%CI: 0.98-1.19), 1.08 (95%CI: 0.97-1.21), and 1.16 (95%CI: 1.02-1.32), respectively. Conclusions: Hypertension duration is positively associated with the risk for chronic kidney disease in residents in China, and this association is independent of blood pressure level. Early diagnosis of hypertension and long-term control of blood pressure are effective strategies for secondary prevention of hypertension-related chronic kidney disease.

[中国居民高血压病程与慢性肾脏疾病的关系]。
目的:评价中国居民高血压病程与慢性肾脏疾病风险的关系。方法:纳入2018年第6轮中国慢性病及危险因素监测的18-74岁受试者。他们报告高血压诊断时的年龄/日期,根据诊断时的年龄和调查时的年龄计算高血压病程。高血压持续时间计算为0年(即血压正常的参与者)、0.1年、5.0年、10.0年和≥15.0年。测定血清肌酐、尿白蛋白和尿肌酐水平,当肾小球滤过率为-1·(1.73 m2)-1和/或尿白蛋白/肌酐比值≥30 mg/g时诊断为慢性肾病。采用多变量logistic回归分析,考虑组内相关性,评估高血压持续时间与慢性肾脏疾病的关系。结果:最终纳入分析的居民共140662人。在调整包括血压在内的混杂因素后,与血压正常者相比,高血压持续时间为0.1-4.9年、5.0-9.9年、10.0-14.9年和≥15.0年的研究对象患慢性肾脏疾病的比值比分别为1.16 (95%CI: 1.09-1.23)、1.33 (95%CI: 1.20-1.48)、1.33 (95%CI: 1.18-1.49)和1.43 (95%CI: 1.29-1.60)。在先前诊断为高血压的人群中,高血压持续时间与慢性肾脏疾病之间的正相关进一步支持了这一结果。限制三次样条结果提示,慢性肾脏疾病的风险在高血压诊断后0.1 ~ 4.9年内急剧增加,之后既没有增加也没有减少。高血压病程5.0 ~ 9.9年、10.0 ~ 14.9年和≥15.0年的患者,上述相关性在诊断年龄(CI: 1.04 ~ 1.84)、1.22 (95%CI: 0.91 ~ 1.65)和1.47 (95%CI: 1.04 ~ 2.07)的高血压患者中更为明显。在≥45岁时诊断为高血压的患者中,相应的比值比分别为1.08 (95%CI: 0.98-1.19)、1.08 (95%CI: 0.97-1.21)和1.16 (95%CI: 1.02-1.32)。结论:中国居民高血压病程与慢性肾脏疾病风险呈正相关,且与血压水平无关。早期诊断高血压,长期控制血压是高血压相关慢性肾脏疾病二级预防的有效策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中华流行病学杂志
中华流行病学杂志 Medicine-Medicine (all)
CiteScore
5.60
自引率
0.00%
发文量
8981
期刊介绍: Chinese Journal of Epidemiology, established in 1981, is an advanced academic periodical in epidemiology and related disciplines in China, which, according to the principle of integrating theory with practice, mainly reports the major progress in epidemiological research. The columns of the journal include commentary, expert forum, original article, field investigation, disease surveillance, laboratory research, clinical epidemiology, basic theory or method and review, etc.  The journal is included by more than ten major biomedical databases and index systems worldwide, such as been indexed in Scopus, PubMed/MEDLINE, PubMed Central (PMC), Europe PubMed Central, Embase, Chemical Abstract, Chinese Science and Technology Paper and Citation Database (CSTPCD), Chinese core journal essentials overview, Chinese Science Citation Database (CSCD) core database, Chinese Biological Medical Disc (CBMdisc), and Chinese Medical Citation Index (CMCI), etc. It is one of the core academic journals and carefully selected core journals in preventive and basic medicine in China.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信